First Time Loading...
Z

Zura Bio Ltd
NASDAQ:ZURA

Watchlist Manager
Zura Bio Ltd
NASDAQ:ZURA
Watchlist
Price: 4.615 USD 3.48%
Updated: Jun 5, 2024

Intrinsic Value

ZURA's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. [ Read More ]

The intrinsic value of one ZURA stock under the Base Case scenario is 1.234 USD. Compared to the current market price of 4.615 USD, Zura Bio Ltd is Overvalued by 73%.

Key Points:
ZURA Intrinsic Value
Base Case
1.234 USD
Overvaluation 73%
Intrinsic Value
Price
Z
Worst Case
Base Case
Best Case

Valuation Backtest
Zura Bio Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ZURA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Ask me anything about
Zura Bio Ltd

Provide an overview of the primary business activities
of Zura Bio Ltd.

What unique competitive advantages
does Zura Bio Ltd hold over its rivals?

What risks and challenges
does Zura Bio Ltd face in the near future?

Has there been any significant insider trading activity
in Zura Bio Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Zura Bio Ltd.

Provide P/S
for Zura Bio Ltd.

Provide P/E
for Zura Bio Ltd.

Provide P/OCF
for Zura Bio Ltd.

Provide P/FCFE
for Zura Bio Ltd.

Provide P/B
for Zura Bio Ltd.

Provide EV/S
for Zura Bio Ltd.

Provide EV/GP
for Zura Bio Ltd.

Provide EV/EBITDA
for Zura Bio Ltd.

Provide EV/EBIT
for Zura Bio Ltd.

Provide EV/OCF
for Zura Bio Ltd.

Provide EV/FCFF
for Zura Bio Ltd.

Provide EV/IC
for Zura Bio Ltd.

Show me price targets
for Zura Bio Ltd made by professional analysts.

What are the Revenue projections
for Zura Bio Ltd?

How accurate were the past Revenue estimates
for Zura Bio Ltd?

What are the Net Income projections
for Zura Bio Ltd?

How accurate were the past Net Income estimates
for Zura Bio Ltd?

What are the EPS projections
for Zura Bio Ltd?

How accurate were the past EPS estimates
for Zura Bio Ltd?

What are the EBIT projections
for Zura Bio Ltd?

How accurate were the past EBIT estimates
for Zura Bio Ltd?

Compare the revenue forecasts
for Zura Bio Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Zura Bio Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Zura Bio Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Zura Bio Ltd compared to its peers.

Compare the P/E ratios
of Zura Bio Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Zura Bio Ltd with its peers.

Analyze the financial leverage
of Zura Bio Ltd compared to its main competitors.

Show all profitability ratios
for Zura Bio Ltd.

Provide ROE
for Zura Bio Ltd.

Provide ROA
for Zura Bio Ltd.

Provide ROIC
for Zura Bio Ltd.

Provide ROCE
for Zura Bio Ltd.

Provide Gross Margin
for Zura Bio Ltd.

Provide Operating Margin
for Zura Bio Ltd.

Provide Net Margin
for Zura Bio Ltd.

Provide FCF Margin
for Zura Bio Ltd.

Show all solvency ratios
for Zura Bio Ltd.

Provide D/E Ratio
for Zura Bio Ltd.

Provide D/A Ratio
for Zura Bio Ltd.

Provide Interest Coverage Ratio
for Zura Bio Ltd.

Provide Altman Z-Score Ratio
for Zura Bio Ltd.

Provide Quick Ratio
for Zura Bio Ltd.

Provide Current Ratio
for Zura Bio Ltd.

Provide Cash Ratio
for Zura Bio Ltd.

What is the historical Revenue growth
over the last 5 years for Zura Bio Ltd?

What is the historical Net Income growth
over the last 5 years for Zura Bio Ltd?

What is the current Free Cash Flow
of Zura Bio Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Zura Bio Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zura Bio Ltd

Current Assets 100.8m
Cash & Short-Term Investments 99.8m
Other Current Assets 1m
Current Liabilities 20.3m
Accounts Payable 20.2m
Accrued Liabilities 111k
Non-Current Liabilities 21.2m
Long-Term Debt 990k
Other Non-Current Liabilities 20.2m
Efficiency

Earnings Waterfall
Zura Bio Ltd

Revenue
0 USD
Operating Expenses
-63.3m USD
Operating Income
-63.3m USD
Other Expenses
3.1m USD
Net Income
-60.2m USD

Free Cash Flow Analysis
Zura Bio Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ZURA Profitability Score
Profitability Due Diligence

Zura Bio Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Positive 3-Year Average ROIC
Negative Free Cash Flow
Negative Operating Income
43/100
Profitability
Score

Zura Bio Ltd's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

ZURA Solvency Score
Solvency Due Diligence

Zura Bio Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
64/100
Solvency
Score

Zura Bio Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZURA Price Targets Summary
Zura Bio Ltd

Wall Street analysts forecast ZURA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZURA is 17.51 USD with a low forecast of 10.1 USD and a high forecast of 27.3 USD.

Lowest
Price Target
10.1 USD
119% Upside
Average
Price Target
17.51 USD
279% Upside
Highest
Price Target
27.3 USD
492% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ZURA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ZURA Price
Zura Bio Ltd

1M 1M
-2%
6M 6M
+7%
1Y 1Y
-29%
3Y 3Y
-43%
5Y 5Y
-43%
10Y 10Y
-43%
Annual Price Range
4.615
52w Low
2.05
52w High
12.8
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -94%
Shares Statistics
Market Capitalization 290.1m USD
Shares Outstanding 63 683 800
Percentage of Shares Shorted 1.62%

ZURA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Zura Bio Ltd

Country

United States of America

Industry

Biotechnology

Market Cap

290.1m USD

Dividend Yield

0%

Description

Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. The company is headquartered in La Jolla, California. The company went IPO on 2021-07-16. The firm is advancing immunology assets into phase II development programs, including ZB-168 and torudokimab. ZB-168 is an anti-interleukin-7 receptor subunit alpha (IL7Rα) inhibitor that has the potential to impact diseases driven by interleukin-7 (IL7) and thymic stromal lymphopoietin (TSLP) biological pathways. The firm focuses on developing a portfolio of therapeutic indications for ZB-168 that build on existing Phase Ib data in type 1 diabetes demonstrating a safety profile and biological rationale. Torudokimab is a fully human, high affinity monoclonal antibody that neutralizes interleukin-33 (IL33), and is in the phase II clinical development stage.

Contact

CALIFORNIA
La Jolla
4225 Executive Square, Suite 600
+18582470520
https://zurabio.com/

IPO

2021-07-16

Employees

-

Officers

Founder & Non-Independent Director
Dr. Someit Sidhu M.D.
Chief Financial Officer
Mr. Verender S. Badial
Chief Scientific Officer
Dr. Michael D. Howell Ph.D.
Chief Legal Officer & Secretary
Ms. Kimberly Ann Davis
President, CEO & COO
Mr. Robert Lisicki
Chief Technology Officer
Dr. Gary Whale Ph.D.
Show More
Chief Human Resources Officer
Ms. Theresa Lowry
Head of Business Development
Mr. David Brady
Chief Medical Officer & Head of Development
Dr. Kiran Nistala MBBS, Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one ZURA stock?

The intrinsic value of one ZURA stock under the Base Case scenario is 1.234 USD.

Is ZURA stock undervalued or overvalued?

Compared to the current market price of 4.615 USD, Zura Bio Ltd is Overvalued by 73%.